![Avisi technologies](/api/images/company-pic/0-1090535-company.png)
Contact us
About company
Avisi Technologies develops a nanotechnology-enabled defense against blindness from glaucoma. Avisi's product, VisiPlate, is a next-generation aqueous shunt that aims to treat mid to late-stage glaucoma. It is 20x thinner than a human hair. VisiPlate leverages an ultrathin nanoplate and its insertion procedure reduces operating time and makes follow-up care easier. VisiPlate is made of alumina, an implant material that has been used in hip replacements. Avisi Technologies is headquartered in Philadelphia, Pennsylvania.
US
Unknown
Not verified company
Business transparency
- Did not verified company info
- Ask their customers for reviews
- Did not replied to negative reviews